Ames MM - Search Results

1

Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the rat.

Ames MM, Mathiesen DA, Reid JM. Ames MM, et al. Invest New Drugs. 1991 Aug;9(3):219-25. doi: 10.1007/BF00176974. Invest New Drugs. 1991. PMID: 1783521

2

Pyrazine diazohydroxide (NSC-361456). Phase I clinical and pharmacokinetic studies.

Dhodapkar MV, Richardson RL, Reid JM, Ames MM. Dhodapkar MV, et al. Among authors: ames mm. Invest New Drugs. 1994;12(3):207-16. doi: 10.1007/BF00873961. Invest New Drugs. 1994. PMID: 7896539 Clinical Trial.

3

Phase I trial of diaziquone (AZQ) plus GM-CSF.

Hartmann LC, Ames MM, Reid JM, Richardson RL. Hartmann LC, et al. Among authors: ames mm. Invest New Drugs. 1995;13(2):175-6. doi: 10.1007/BF00872869. Invest New Drugs. 1995. PMID: 8617583 Clinical Trial.

4

High-performance liquid chromatographic assay and preclinical pharmacologic studies with the experimental antitumor agent batracylin.

Ames MM, Mathiesen DA. Ames MM, et al. J Chromatogr. 1989 Jul 21;491(2):488-94. doi: 10.1016/s0378-4347(00)82870-4. J Chromatogr. 1989. PMID: 2808633 No abstract available.

5

Murine pharmacokinetics and metabolism of penclomedine [3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine, NSC 338720].

Reid JM, Mathiesen DA, Benson LM, Kuffel MJ, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Res. 1992 May 15;52(10):2830-4. Cancer Res. 1992. PMID: 1581896

6

Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report.

Reid JM, Pendergrass TW, Krailo MD, Hammond GD, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Res. 1990 Oct 15;50(20):6525-8. Cancer Res. 1990. PMID: 2208112 Clinical Trial.

7

Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone).

Frank SK, Mathiesen DA, Szurszewski M, Kuffel MJ, Ames MM. Frank SK, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1989;23(4):213-8. doi: 10.1007/BF00451644. Cancer Chemother Pharmacol. 1989. PMID: 2924379

8

High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.

Frank SK, Mathiesen DA, Whitfield LR, Ames MM. Frank SK, et al. Among authors: ames mm. J Chromatogr. 1987 Aug 7;419:225-32. doi: 10.1016/0378-4347(87)80280-3. J Chromatogr. 1987. PMID: 3667780

9

Preclinical pharmacology of cholera toxin.

Reid JM, Benson JW, Viallet J, Ames MM. Reid JM, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1995;36(2):115-20. doi: 10.1007/BF00689194. Cancer Chemother Pharmacol. 1995. PMID: 7767946

10

Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065.

Walker DL, Reid JM, Ames MM. Walker DL, et al. Among authors: ames mm. Cancer Chemother Pharmacol. 1994;34(4):317-22. doi: 10.1007/BF00686039. Cancer Chemother Pharmacol. 1994. PMID: 8033298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters